VAI-SU2C Epigenetics Dream Team Archives

October 11, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…

June 12, 2017 VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers

GRAND RAPIDS, Mich. (June 13, 2017)—A new clinical trial spanning three cancer centers in California, Maryland and Pennsylvania is investigating a promising…

May 14, 2017 Dr. Stephen Baylin becomes third VARI-affiliated scientist to be elected to National Academy of Sciences

VARI-affiliated cancer researcher Stephen Baylin, M.D., has been elected to the National Academy of Sciences…

March 6, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial

GRAND RAPIDS, Mich. (March 7,…

March 1, 2017 Three things to know about colorectal cancer

March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key…

December 29, 2016 What difference does a year make?

When it comes to biomedical research and science education, a year can make all the difference. In 2016, we celebrated Van Andel…

October 9, 2016 Combinations and collaborations in the fight against cancer: An interview with Dr. Feyruz Rassool and Dr. Stephen Baylin

What happens when scientists collaborate rather than compete? In this case, the result is a combination of two drugs that may be a more effective…

September 13, 2016 Stand Up To Cancer hosts another incredible telecast!

Last Friday, Stand Up To Cancer (SU2C) hosted its fifth live telecast, which brought together top scientists, actors and musicians in support of cancer research.

…